Lubiprostone Does Not Affect Serum Electrolytes and Markers of Renal Function in Patients With Irritable Bowel Syndrome With Constipation

被引:0
|
作者
Rao, Satish [1 ]
Johanson, John [2 ]
Spierings, Egilius [3 ,4 ,5 ]
Lichtlen, Peter [6 ]
Habibi, Sepideh [7 ]
机构
[1] Georgia Regents Univ, Augusta, GA USA
[2] Univ Illinois, Coll Med, Rockford, IL 61107 USA
[3] Tufts Univ, Sch Dent Med, Craniofacial Pain Ctr, Boston, MA 02111 USA
[4] Tufts Med Ctr, Headache & Face Pain Program, Dept Neurol, Boston, MA USA
[5] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA
[6] Sucampo AG, Zug, Switzerland
[7] Sucampo Pharma Amer LLC, Bethesda, MD USA
来源
关键词
D O I
10.14309/00000434-201410002-01812
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1812
引用
收藏
页码:S536 / S536
页数:1
相关论文
共 50 条
  • [41] Reasons for Treatment Discontinuation in Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
    Shah, Eric
    Lacy, Brian E.
    Chey, William D.
    Mavrommatis, Evan
    Li, Moming
    Reid, Kayla
    Brenner, Darren M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S505 - S506
  • [42] Why Patients with Chronic Constipation or Irritable Bowel Syndrome with Constipation are not Satisfied of their Defecation with Therapy?
    Basilisco, G.
    Barbara, G.
    Bellini, M.
    Cataudella, G.
    D'alba, L.
    Guarino, M.
    Iovino, P.
    Neri, M. C.
    Sarnelli, G.
    Savarino, E.
    Tolone, S.
    Torresan, F.
    Usai-Satta, P.
    Lovati, A.
    Arsie, E.
    Coletta, M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [43] Effects of Lubiprostone on Gastrointestinal Symptoms, Bowel Function, and Bowel Satisfaction in Patients with Methanogenic Flora and Chronic Constipation
    Rao, Satish
    Meduri, Kalyani
    Tuteja, Ashok
    Schey, Ron
    Schulze, Konrad
    Valestin, Jessica
    Summers, Robert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S712 - S713
  • [44] DOES BOWEL FUNCTION CHANGE IN IRRITABLE BOWEL SYNDROME PATIENTS UNDERGOING NEUROMODULATION FOR VOIDING DYSFUNCTION?
    Peters, Kenneth M.
    Killinger, Kim A.
    Kangas, Jeffrey R.
    Boura, Judith A.
    NEUROUROLOGY AND URODYNAMICS, 2010, 29 (02) : 262 - 262
  • [45] Markers for Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome
    Ludidi, Samefko
    Mujagic, Zlatan
    Jonkers, Daisy
    Keszthelyi, Daniel
    Hesselink, Martine
    Kruimel, Joanna
    Conchillo, Jose M.
    Masclee, Ad
    GASTROENTEROLOGY, 2014, 146 (05) : S534 - S534
  • [46] Markers for visceral hypersensitivity in patients with irritable bowel syndrome
    Ludidi, S.
    Mujagic, Z.
    Jonkers, D.
    Keszthelyi, D.
    Hesselink, M.
    Kruimel, J.
    Conchillo, J.
    Masclee, A.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (08): : 1104 - 1111
  • [47] Treatment patterns, symptom reduction, quality of life, and resource use associated with lubiprostone in irritable bowel syndrome constipation subtype
    Solem, Caitlyn T.
    Patel, Haridarshan
    Mehta, Sonam
    Mody, Reema
    Macahilig, Cynthia
    Gao, Xin
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (05) : 899 - 905
  • [48] The role of rifaximin therapy in patients with irritable bowel syndrome without constipation
    Schey, Ron
    Rao, Satish S. C.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 5 (04) : 461 - 464
  • [49] Sensory signalling effects of tegaserod in patients with irritable bowel syndrome with constipation
    Sabate, J. -M.
    Bouhassira, D.
    Poupardin, C.
    Wagner, A.
    Loria, Y.
    Coffin, B.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2008, 20 (02): : 134 - 141
  • [50] PREVALANCE AND INVESTIGATIONAL PATHWAYS OF PATIENTS WITH CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME
    Lin, S.
    Kurien, M.
    Aziz, I.
    Winfield, S.
    Rugg, N.
    Kelsall, A.
    Leeds, J. S.
    Sanders, D. S.
    GUT, 2013, 62 : A101 - A102